| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 118.48B | 123.56B | 114.05B | 106.62B | 107.99B | 88.33B |
| Gross Profit | 30.69B | 30.81B | 30.31B | 28.76B | 27.43B | 23.13B |
| EBITDA | 9.65B | 5.29B | 9.54B | 8.88B | 8.79B | 4.97B |
| Net Income | 2.23B | -1.39B | 2.78B | 2.24B | 2.05B | -83.00M |
Balance Sheet | ||||||
| Total Assets | 118.13B | 132.38B | 124.35B | 114.84B | 111.79B | 104.06B |
| Cash, Cash Equivalents and Short-Term Investments | 17.24B | 18.95B | 20.30B | 17.48B | 14.44B | 13.71B |
| Total Debt | 33.19B | 38.48B | 33.95B | 33.90B | 35.31B | 31.18B |
| Total Liabilities | 56.98B | 69.48B | 60.31B | 57.04B | 58.86B | 53.83B |
| Stockholders Equity | 61.06B | 62.82B | 63.94B | 57.68B | 52.81B | 50.12B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -2.15B | 5.74B | 6.51B | -288.00M | -8.25B |
| Operating Cash Flow | 0.00 | 3.32B | 9.08B | 9.51B | 2.18B | -4.95B |
| Investing Cash Flow | 0.00 | -5.27B | -3.90B | -2.67B | -2.64B | -4.62B |
| Financing Cash Flow | 0.00 | 316.00M | -3.64B | -4.01B | 591.00M | 4.54B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥11.34T | 20.30 | 8.95% | 1.88% | 5.02% | 2.02% | |
74 Outperform | ¥5.68T | 64.56 | ― | 1.41% | 13.61% | 17.01% | |
70 Outperform | ¥849.22B | 31.17 | ― | 2.57% | 4.07% | 533.21% | |
67 Neutral | ¥44.48B | 12.31 | ― | 4.53% | 5.02% | 354.47% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | ¥32.21B | 5.44 | ― | 1.95% | 7.56% | ― | |
54 Neutral | ¥76.31B | -34.47 | 3.63% | 2.25% | 8.34% | -150.77% |